Hecogenin structure
|
Common Name | Hecogenin | ||
---|---|---|---|---|
CAS Number | 467-55-0 | Molecular Weight | 430.620 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 548.9±50.0 °C at 760 mmHg | |
Molecular Formula | C27H42O4 | Melting Point | 268°C | |
MSDS | N/A | Flash Point | 177.8±23.6 °C |
Use of HecogeninHecogenin is a steroid saponin isolated from Agave sisalana and is a selective inhibitor of human UDP-glucuronosyltransferases. Hecogenin has a wide spectrum of pharmacological activities, including anti-inflammatory, antifungal and gastroprotective effects[1]. |
Name | Hecogenin |
---|---|
Synonym | More Synonyms |
Description | Hecogenin is a steroid saponin isolated from Agave sisalana and is a selective inhibitor of human UDP-glucuronosyltransferases. Hecogenin has a wide spectrum of pharmacological activities, including anti-inflammatory, antifungal and gastroprotective effects[1]. |
---|---|
Related Catalog | |
Target |
Human UDP-glucuronosyltransferases[1] |
In Vivo | Hecogenin (3.1-90 mg/kg; oral administration; for 15 hours; male Swiss mice) acutely administered, before ethanol, exhibits a potent gastroprotective effect. The Hecogenin pretreatment normalizes GSH levels and significantly reduces lipid peroxidation and nitrite levels in the stomach, as evaluated by the ethanol-induced gastric lesion model. Hecogenin also decreases MPO release and significantly protects the gastric mucosa[1]. Animal Model: Male Swiss mice (20-30 g) with ethanol[1] Dosage: 3.1 mg/kg, 7.5 mg/kg, 15 mg/kg, 30 mg/kg, 60 mg/kg and 90 mg/kg Administration: Oral administration; for 15 hours Result: Normalized GSH levels and significantly reduced lipid peroxidation and nitrite levels in the stomach, as evaluated by the ethanol-induced gastric lesion model. Decreased MPO release and significantly protected the gastric mucosa. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 548.9±50.0 °C at 760 mmHg |
Melting Point | 268°C |
Molecular Formula | C27H42O4 |
Molecular Weight | 430.620 |
Flash Point | 177.8±23.6 °C |
Exact Mass | 430.308319 |
PSA | 55.76000 |
LogP | 4.22 |
Vapour Pressure | 0.0±3.3 mmHg at 25°C |
Index of Refraction | 1.559 |
Hazard Codes | Xi |
---|---|
Risk Phrases | R36/37/38:Irritating to eyes, respiratory system and skin . |
Safety Phrases | S26-S36 |
WGK Germany | 3 |
Precursor 7 | |
---|---|
DownStream 6 | |
5ALPHA-SPIROSTAN-3BETA-OL-12-ONE |
5α-Spirostan-12-one, 3β-hydroxy-, (25R)- |
(25R)-5-Spirostan-3-ol-12-one |
MFCD00067285 |
(22R,25R)-3β-Hydroxy-5α-spirostan-12-one |
Spirostan-12-one, 3-hydroxy-, (3β,5α,25R)- |
12-Oxotigogenin |
(3β,5α,25R)-3-Hydroxyspirostan-12-one |
Hocogenin |
Hecoginin |
(25R)-3b-Hydroxy-5a-spirostan-12-one |
Hecogenin |
EINECS 207-392-4 |
3-b-Hydroxy-5-a-spirostan-12-one |
(3,5,25R)-3-Hydroxysiprostan-1 |
(3,5,25R)-3-Hydroxysiprostan-12-one |
(3b,5a,25R)-3-Hydroxyspirostan-12-one |